|
|
Article: News and FDA Updates for 3SBio (Nasdaq:SSRX), TomoTherapy (NASDAQ:TOMO).
- Article from:
- M2 Presswire
- Article date:
- October 28, 2009
CopyrightCOPYRIGHT 2009 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-28 October 2009-BiomedReports: News and FDA Updates for 3SBio (Nasdaq:SSRX), TomoTherapy (NASDAQ:TOMO)(C)1994-2009 M2 COMMUNICATIONS
RDATE:28102009
Pasadena, CA -- BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.
A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com
On 10/27/09, 3SBio Inc. (Nasdaq:SSRX), a leading China-based ...